<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36190929</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1948-7193</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>20</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>ACS chemical neuroscience</Title><ISOAbbreviation>ACS Chem Neurosci</ISOAbbreviation></Journal><ArticleTitle>Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID.</ArticleTitle><Pagination><StartPage>2934</StartPage><EndPage>2938</EndPage><MedlinePgn>2934-2938</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschemneuro.2c00482</ELocationID><Abstract><AbstractText>With reports of diverse neurological deficits in the acute phase of COVID-19, there is a surge in neurological findings in Long-COVID&#x2500;a protracted phase of SARS-CoV-2 infection. Very little is known regarding the pathogenic mechanisms of Neuro-COVID in the above two settings in the current pandemic. Herein, we hint toward the possible molecular mechanism that can contribute to the signs and symptoms of patients with neurological deficits and possible treatment and prevention modalities in the acute and chronic phases of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baig</LastName><ForeName>Abdul Mannan</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-0626-216X</Identifier><AffiliationInfo><Affiliation>Department of Biological and Biomedical Sciences, Aga Khan University, Karachi 74800, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greig</LastName><ForeName>Nigel H</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0002-3032-1468</Identifier><AffiliationInfo><Affiliation>National Institute on Aging, Baltimore, Maryland 21224, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerlach</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health-Shield, Vedicinals-9 40764 Langenfeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salunke</LastName><ForeName>Prakash</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>German-Indian Biotech Vedicinals-9 Talawade, Pune 412114, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabrowski</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Royal Sussex County Hospital, University Hospitals Sussex, Brighton BN2 5BE, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viduto</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Long-COVID Foundation Garforth, Leeds, West Yorkshire LS25 1NB, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Tazeen</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biological and Biomedical Sciences, Aga Khan University, Karachi 74800, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Neurosci</MedlineTA><NlmUniqueID>101525337</NlmUniqueID><ISSNLinking>1948-7193</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Neuro-COVID</Keyword><Keyword MajorTopicYN="N">Neurological Deficits</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">Treatment Long-COVID</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36190929</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.2c00482</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>